title: Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.
authors.affiliation: Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome Trust, Addenbrooke's Hospital, University of Cambridge Cambridge, UK.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Renna
keywords: cancer therapeutics; drug design; mTOR inhibitors; mTOR pathway; resistance mechanisms